Key result
Percutaneous epicardial mapping for VT ablation can cause rare iatrogenic pleuropericardial communication.
Why the study?
Epicardial access for VT ablation is increasingly performed but carries risks of cardiac complications, with rare complications like iatrogenic pleuropericardial communication not well characterized.
Case Report
Highlights iatrogenic pleuropericardial communication as a rare complication of percutaneous epicardial mapping for ventricular tachycardia ablation.
Answers are grounded in this paper and cite their sources.
May support first-line epicardial VT ablation in select cardiomyopathies; hypothesis-generating and requires prospective validation.
Ablation of ventricular tachycardia (VT) is a well-established treatment for patients with recurrent implantable cardioverter-defibrillator shocks. Epicardial access is increasingly performed when epicardial arrhythmogenic substrate is suspected and may be considered as a first-line approach in the subset of myocardial diseases with preferential epicardial substrate, namely, idiopathic dilated cardiomyopathy, arrhythmogenic right ventricular dysplasia, or chagasic cardiomyopathy. Cardiac complications of this approach include right ventricular puncture, pericardial bleeding, coronary vessel damage, and pericarditis.
No takes yet. Share an insight, caveat, or question.
Bisbal et al. (2017) conducted a case report in Ventricular tachycardia. Percutaneous epicardial mapping was evaluated. Percutaneous epicardial mapping for ventricular tachycardia ablation can result in iatrogenic pleuropericardial communication, a rare complication.
Synapse has enriched 10 related papers. Consider them for comparative context: